CELLective Dx Corporation cellectivedx.com


CELLective Dx is an early-stage company developing a new generation of diagnostic tools for cancer based on analysis of CTCs directly from a patient's blood. Our novel proprietary technologies combine microfluidics, flow dynamics, cell biology, molecular biology, biochemistry, and surface chemistry to capture and analyze rare CTCs in blood more rapidly and effectively than other current technologies. CELLective Dx is developing simple, rapid, blood-based cancer tests that will provide physicians...Show all

CELLective Dx is an early-stage company developing a new generation of diagnostic tools for cancer based on analysis of CTCs directly from a patient's blood. Our novel proprietary technologies combine microfluidics, flow dynamics, cell biology, molec...Show all

Company (Alive / Active)

Phone: 650-938-9800

Fax:

265 North Whisman Road
Mountain View, 94043
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
CELLective Dx Corporation $24.7M Oct 13, 2008
ARIAD Pharmaceuticals $20.1M Feb 17, 2017
BioForce Nanosciences $4.1M Nov 17, 2008
See all 20 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related CELLective Dx Corporation Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 20 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Tagged ligands for enrichment of rare analytes from a mixed sample Feb 25, 2008 Aug 30, 2011 Patent